Joseph F. Rizzo III
Tracked across 1 events · 20 articles · First seen Sep 21, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Hundreds of patients in the United States have filed personal injury lawsuits against Novo Nordisk and Eli Lilly and Company, alleging that widely used GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity caused a…
Impact: Dr Joseph F. Rizzo III authored a 2024 study linking semaglutide to increased NAION risk, providing a scientific basis for the lawsuits, though he has cautioned against stopping medication based on his findings.
Sep 21, 2026 · 20 articles
ERGEN INTELLIGENCE
Track Joseph F. Rizzo III live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard